112 related articles for article (PubMed ID: 19840482)
1. [Clinical analysis of 14 patients with lymphoma associated hemophagocytic syndrome].
Wang JS; Wang Z; Wu L; Tian LP; Chen X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1352-5. PubMed ID: 19840482
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome.
Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M
Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240
[TBL] [Abstract][Full Text] [Related]
3. Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation.
Zou H; He L; Hue Z; Liu M; Yao S; Zhu Y; Wang Z; Wang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8521-8533. PubMed ID: 37093345
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Jin Z; Wang Y; Wang J; Wu L; Pei R; Lai W; Wang Z
Hematology; 2018 May; 23(4):228-234. PubMed ID: 28982299
[TBL] [Abstract][Full Text] [Related]
5. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome.
Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X
Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and prognosis of lymphoma-associated hemophagocytic syndrome].
Zhao AL; Li M; Li LF; Gan XA; Wang J; Li H; Shen K; Yang YF; Niu T
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2173-2180. PubMed ID: 35872581
[No Abstract] [Full Text] [Related]
7. An effective diagnostic index for lymphoma-associated hemophagocytic syndrome.
Xie M; Li L; Zhu L; Zhou D; Yang X; Sun J; Zhu J; Zhu M; Zheng Y; Xie W; Ye X
QJM; 2018 Aug; 111(8):541-547. PubMed ID: 29800321
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome.
Han AR; Lee HR; Park BB; Hwang IG; Park S; Lee SC; Kim K; Lim HY; Ko YH; Kim SH; Kim WS
Ann Hematol; 2007 Jul; 86(7):493-8. PubMed ID: 17347847
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
He Y; Gao Y; Ping L; He H; Huang C; Bai B; Wang X; Li Z; Cai Q; Huang Y; Pan X; Zeng W; Liu Y; Huang H
J Cancer Res Clin Oncol; 2023 May; 149(5):2017-2027. PubMed ID: 35809114
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of lymphocyte function by IFN-γ secretion capability assay in the diagnosis of lymphoma-associated hemophagocytic syndrome.
Hou H; Luo Y; Wang F; Yu J; Li D; Sun Z
Hum Immunol; 2019 Dec; 80(12):1006-1011. PubMed ID: 31540793
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome.
Tong H; Ren Y; Liu H; Xiao F; Mai W; Meng H; Qian W; Huang J; Mao L; Tong Y; Wang L; Qian J; Jin J
Leuk Lymphoma; 2008 Jan; 49(1):81-7. PubMed ID: 18203016
[TBL] [Abstract][Full Text] [Related]
12. [The diagnostic value of flow cytometry in patients with lymphoma associated hemophagocytic syndrome].
Zhang WL; Xu L; Zhang Q; Zhong FL; Dai J; Feng J; Sun LH; Xu HC; Xie WY; Zhang HY
Zhonghua Nei Ke Za Zhi; 2020 Dec; 59(12):976-981. PubMed ID: 33256339
[No Abstract] [Full Text] [Related]
13. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China.
Li F; Li P; Zhang R; Yang G; Ji D; Huang X; Xu Q; Wei Y; Rao J; Huang R; Chen G
Med Oncol; 2014 Apr; 31(4):902. PubMed ID: 24610542
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma-associated hemophagocytic syndrome in six dogs.
Suwa A; Shimoda T
J Vet Med Sci; 2018 Aug; 80(8):1271-1276. PubMed ID: 29937462
[TBL] [Abstract][Full Text] [Related]
15. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Tsuji T; Hirano T; Yamasaki H; Tsuji M; Tsuda H
Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
[TBL] [Abstract][Full Text] [Related]
16. [Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome].
Nagao T; Takahashi N; Saitoh H; Noguchi S; Guo YM; Ito M; Watanabe A; Fujishima N; Kameoka Y; Tagawa H; Hirokawa M; Sawada K
Rinsho Ketsueki; 2012 Dec; 53(12):2008-12. PubMed ID: 23318967
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic syndrome associated with large granular lymphoma in an adult dog.
Varvil MS; Messick JB; Dos Santos AP
Vet Clin Pathol; 2022 Mar; 51(1):115-118. PubMed ID: 35141916
[TBL] [Abstract][Full Text] [Related]
18. [Children's NK/T Cell Lymphoma-Associated Hemophagocytic Syndrome: Clinical Analysis of 6 Cases].
Zheng YZ; Zheng H; Li J; LE SH; Hua XL; Chen ZS; Zheng L; Li M; Chen YQ; Gao QL; Yang JH; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1764-1770. PubMed ID: 28024491
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center.
Li N; Jiang M; Wu WC; Zhou HJ; Zou LQ
Hematology; 2022 Dec; 27(1):909-916. PubMed ID: 35993333
[TBL] [Abstract][Full Text] [Related]
20. Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes: a multicentre study.
Sano H; Kobayashi R; Tanaka J; Hashino S; Ota S; Torimoto Y; Kakinoki Y; Yamamoto S; Kurosawa M; Hatakeyama N; Haseyama Y; Sakai H; Sato K; Fukuhara T
Br J Haematol; 2014 Jun; 165(6):786-92. PubMed ID: 24606577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
